Drug-induced psychosis following use of Ayahuasca: a presentation to forensic psychiatric services

Ayahuasca is a plant-based psychoactive decoction, traditionally used by indigenous Amazonian peoples, which commonly contains the hallucinogen N,N-dimethyltryptamine (DMT). There is now growing interest across the Western world in psychedelics including Ayahuasca.This case describes a previously well male with no risk factors for adverse psychiatric outcomes or forensic history. Following controlled Ayahuasca use, he developed an enduring psychotic episode, during which he significantly assaulted a relative and was admitted to a forensic psychiatric unit. He was treated with the antipsychotic aripiprazole, and his psychotic symptoms abated. 18 months following his admission, recovery has been sustained.Previous case reports have described psychosis following Ayahuasca ingestion, but typically of short duration in patients with a personal or family history of psychiatric illness, or in those taking other substances. With the growing use of Ayahuasca, it is important to highlight that adverse effects may include more prolonged psychotic symptoms and the risk of psychotically mediated violence.

Authors

Institutions

Publication Details

Journal
BMJ Case Reports
Published
2024-08-01
DOI
https://doi.org/10.1136/bcr-2024-260648
Citations
1
Primary Topic
Psychedelics and Drug Studies
Type
article
Field-Weighted Citation Impact
0.64
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Drug-induced psychosis following use of Ayahuasca: a presentation to forensic psychiatric services

M. Baker, Christopher Iain O'Shea
1 citations
BMJ Case Reports
Psychedelics and Drug Studies
0.64
article

Drug-induced psychosis following use of Ayahuasca: a presentation to forensic psychiatric services

M. Baker, Christopher Iain O'Shea
article en
1 citations

Abstract

Ayahuasca is a plant-based psychoactive decoction, traditionally used by indigenous Amazonian peoples, which commonly contains the hallucinogen N,N-dimethyltryptamine (DMT). There is now growing interest across the Western world in psychedelics including Ayahuasca.This case describes a previously well male with no risk factors for adverse psychiatric outcomes or forensic history. Following controlled Ayahuasca use, he developed an enduring psychotic episode, during which he significantly assaulted a relative and was admitted to a forensic psychiatric unit. He was treated with the antipsychotic aripiprazole, and his psychotic symptoms abated. 18 months following his admission, recovery has been sustained.Previous case reports have described psychosis following Ayahuasca ingestion, but typically of short duration in patients with a personal or family history of psychiatric illness, or in those taking other substances. With the growing use of Ayahuasca, it is important to highlight that adverse effects may include more prolonged psychotic symptoms and the risk of psychotically mediated violence.

BMJ Case ReportsVol. 17(8)
Royal Edinburgh Hospital (GB)
Openalex Percentile: Top 29%
Psychedelics and Drug Studies
0.64
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Drug-induced psychosis following use of Ayahuasca: a presentation to forensic psychiatric services — M. Baker, Christopher Iain O'Shea · BMJ Case Reports (2024) | TGRS Research Map | TGRS